UCB (http://www.ucb.com/) is a global leader in the biopharmaceutical industry 
dedicated to the research, development and commercialization of innovative 
pharmaceutical and biotechnology products in the fields of central nervous 
system disorders, and immune and inflammatory disorders. UCB focuses on 
securing a leading position in severe disease categories.  At the Research 
Centre of "UCB New Medicines", we are seeking to recruit  talented PhD. level 
PK-PD/M&S experts to join our pharmacometrics team.  The role will be 
predominantly positioned in the translational to early-phase/POC field driving 
quantitative pharmacology modeling at a project team level.  An interest and 
experience in mechanistic modeling is a must.  The positions can be located 
either in UK (slough) or Belgium.  For further information, please
contact:<mailto:[email protected]> [email protected]

________________________________
UCB Celltech is the UK branch of UCB Pharma S.A., a company registered in 
Belgium with registered offices at All?e de la Recherche 60, 1070 Brussels, 
Belgium, KBO/BCE nr. 0403.096.168, RPR/RPM Brussels.
UCB Celltech's UK branch registration number is BR009137 and its UK 
representative office is at 208 Bath Road, Slough, Berkshire SL1 3WE.

(Ref: #*CUK0308) [Ref-CUK0308]
________________________________
Legal Notice: This electronic mail and its attachments are intended solely for 
the person(s) to whom they are addressed and contain information which is 
confidential or otherwise protected from disclosure, except for the purpose for 
which they are intended. Dissemination, distribution, or reproduction by anyone 
other than the intended recipients is prohibited and may be illegal. If you are 
not an intended recipient, please immediately inform the sender and return the 
electronic mail and its attachments and destroy any copies which may be in your 
possession. UCB screens electronic mails for viruses but does not warrant that 
this electronic mail is free of any viruses. UCB accepts no liability for any 
damage caused by any virus transmitted by this electronic mail. (Ref: #*UG1107) 
[Ref-UG1107]
________________________________

Reply via email to